BGTCF
Beijing Geekplus Technology Co., Ltd./ADR
No data for this timeframe.
Vol
Analyst Ratings
6Strong Buy
12Buy
1Hold
0Sell
0Strong Sell
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 95% buy across 19 analysts — 6 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 6 | 12 | 1 | 0 | 0 | 95% | |
| May 1, 2026 | 6 | 12 | 1 | 0 | 0 | 95% | |
| Apr 1, 2026 | 6 | 12 | 1 | 0 | 0 | 95% | |
| Mar 1, 2026 | 6 | 12 | 1 | 0 | 0 | 95% | |
| Feb 1, 2026 | 6 | 12 | 1 | 0 | 0 | 95% | |
| Jan 1, 2026 | 5 | 10 | 1 | 0 | 0 | 94% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 12, 2026
Clinical Trial
Evaluating Different Doses of Orelabrutinib in MCL
Phase Phase 2 — COMPLETED
Jun 5, 2026
Clinical Trial
A Study of PLB1001 in Non-small Cell Lung Cancer With c-Met Dysregulation(KUNPENG)
Phase Phase 2 — COMPLETED